secwatch.observer — SEC 8-K summary
======================================

Issuer:     BIOTRICITY INC. (BTCY)
CIK:        0001630113
Form:       8-K
Filed at:   2023-01-20T23:59:59+00:00
Accession:  0001493152-23-002082
Event type: other_material
Sentiment:  negative
Materiality: 0.75
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

Biotricity receives Nasdaq bid price deficiency notice; 180 days to cure
------------------------------------------------------------------------

- Nasdaq letter on Jan 20, 2023: closing bid price below $1.00 for 30 consecutive days.
- Company has until July 19, 2023 to regain compliance with Bid Price Rule.
- To regain compliance, bid must close at $1.00+ for 10 consecutive business days.
- If not compliant by deadline, Nasdaq may delist; company may consider reverse stock split.
- No immediate effect on listing or trading of BTCY common stock.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1630113/000149315223002082/0001493152-23-002082-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1630113/000149315223002082/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-23-002082

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer